In vivo behavior of radioiodinated rabbit antithrombin III. Demonstration of a noncirculating vascular compartment.
Open Access
- 1 July 1984
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 74 (1) , 191-199
- https://doi.org/10.1172/jci111401
Abstract
Rabbit antithrombin III (AT), purified by heparin-agarose, was labeled with iodine-131 by either the glucose oxidase-lactoperoxidase or iodine monochloride techniques. When intravenously injected, the disappearance of the 131I-AT from plasma was characterized by rapid initial decreases, and three-exponential equations were required for best fit of the plasma disappearance curves. This rapid 131I-AT removal was not caused by denaturation, as shown by comparison with results obtained when 131I-AT was biologically screened (injected into a first rabbit, and then transferred 16 h later in whole plasma to a second for kinetic evaluation) before injection. Thus, the same rapid initial loss of plasma 131I-AT was observed with screened preparations, and the plasma fractional catabolic rates of 0.716 +/- 0.048 and 0.673 +/- 0.051 day-1 for unscreened and screened 131I-AT were not significantly different. These results support the hypothesis that a vascular-endothelial AT compartment is present in rabbit. The fractions of the total-body AT in the plasma, the vascular-endothelial and the extravascular compartments were 0.337 +/- 0.031, 0.178 +/- 0.056, and 0.485 +/- 0.069, respectively. Two three-compartment kinetic models are discussed. The first pictures AT as distributing independently between plasma and two other compartments, and the second sees AT as first passing to the vascular-endothelial compartment, and then directly into the extravascular compartment. The plasma 131I-AT kinetic data was consistent with both models, but the sizes of the vascular-endothelial compartments were best predicted by the second. If AT catabolism was assigned to the plasma, both models generally underpredicted the whole-body radioactivities, while assignment of breakdown to the extravascular compartment generally resulted in overpredictions. This suggests that AT catabolism occurs from both plasma and extravascular compartments.This publication has 30 references indexed in Scilit:
- KINETIC STUDIES IN VIVO OF ANTITHROMBIN III*Annals of the New York Academy of Sciences, 1981
- Clearance of Thrombin from Circulation in Rabbits by High-affinity Binding Sites on EndotheliumJournal of Clinical Investigation, 1980
- Coated pits, coated vesicles, and receptor-mediated endocytosisNature, 1979
- Quantitation of thrombin‐antithrombin III complexes in human bloodEuropean Journal of Clinical Investigation, 1977
- Metabolism of antithrombin III (heparin cofactor) in man: effects of venous thrombosis and of heparin administrationEuropean Journal of Clinical Investigation, 1977
- Metabolism of plasminogen in healthy subjects: effect of tranexamic acidJournal of Clinical Investigation, 1972
- The Nature and Rates of Excretion of Radioactive Breakdown Products of I131-Albumin in the RabbitThe Journal of general physiology, 1959
- The Kinetics of the Distribution and Breakdown of I131-Albumin in the RabbitThe Journal of general physiology, 1959
- The Theory of Tracer Experiments with 131I-Labelled Plasma ProteinsPhysics in Medicine & Biology, 1957
- THE TURNOVER RATE OF SERUM ALBUMIN IN MAN AS MEASURED BY I131-TAGGED ALBUMIN 1Journal of Clinical Investigation, 1951